Delivery Order SPE2DR25D2005-SPE2DR26FE7M0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for $59,655.00 to supply Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The delivery order was competitively awarded with no set-aside designation and carries a firm fixed-price structure, with an ultimate completion date of November 28, 2025. Performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $18,912.60 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135 DIP 0.5mL, a meningococcal vaccine product. This firm fixed-price contract, with a completion date of June 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,206.14 to AmerisourceBergen Drug Corp for Menveo 1 vial (A-C-Y-W-135-DIP, 0.5ML), a meningococcal conjugate vaccine. The contract, awarded December 9, 2025, with completion targeted for December 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $1,463.66 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine. This firm fixed price, competitively awarded delivery order is scheduled for completion by October 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,231.88 on November 3, 2025, under a firm fixed-price contract. The order covers Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a conjugate meningococcal vaccine, with delivery required by November 4, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to...
- The Defense Logistics Agency awarded a $6,187.14 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a conjugate meningococcal vaccine. This firm fixed-price contract, which represents a child order under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 7, 2025. The award was made through competitive procurement with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $47,123.20 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order is expected to be completed by December 9, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its distribution operations...
- The Defense Logistics Agency awarded a $2,195.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The order is scheduled for completion by June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7M0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,193.10 delivery order on November 25, 2025, for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor for the Defense Logistics Agency's Medical Supply Chain. As a competitively awarded prime contractor, the company maintains an extensive portfolio of pharmaceutical and medical supply deliveries to support military and veteran healthcare systems. The parent IDC enables AmerisourceBergen to supply vaccines, specialty medications, brand-name and generic drugs, and other medical commodities to customers including the Defense Health Agency and U.S. Coast Guard, reinforcing its position as a key healthcare logistics provider for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/24/25 |